BACKGROUND:Environmental enrichment (EE) confers benefits after traumatic brain injury (TBI) when provided daily for > 6 hours, but not 2 or 4 hours, which more accurately reflects the daily amount of clinical rehabilitation. The lack of benefit with sub-therapeutic EE suggests that augmentation with galantamine (GAL), which enhances cognition after TBI, may be indicated to confer benefits. OBJECTIVE: To test the hypothesis that 2 and 4 hours of EE paired with GAL will provide benefits comparable to 24 hours of EE alone. Moreover, all EE groups will perform better than the standard (STD)-housed GAL group. METHODS: Anesthetized rats received a TBI or sham injury and then were randomized to receive intraperitoneal injections of GAL (2 mg/kg) or saline vehicle (VEH; 1 mL/kg) beginning 24 hours after surgery and once daily while receiving EE for 2, 4, or 24 hours. Motor and cognitive assessments were conducted on postoperative days 1-5 and 14-19, respectively. RESULTS:Motor function was significantly improved in the TBI + 24-hour EE group versus the TBI + STD + VEH and TBI + STD + GAL groups ( P < .05). Cognitive performance was enhanced in all EE groups as well as in the TBI + STD + GAL versus TBI + STD + VEH ( P < .05). Moreover, the 2- and 4-hour EE groups receiving GAL did not differ from the 24-hour EE group ( P > .05) and performed better than GAL alone ( P < .05). CONCLUSIONS: The findings support the hypothesis and have clinical relevance because, often, only brief rehabilitation may be available in the clinic and, thus, augmenting with a pharmacotherapy such as GAL may lead to outcomes that are significantly better than either therapy alone.
RCT Entities:
BACKGROUND: Environmental enrichment (EE) confers benefits after traumatic brain injury (TBI) when provided daily for > 6 hours, but not 2 or 4 hours, which more accurately reflects the daily amount of clinical rehabilitation. The lack of benefit with sub-therapeutic EE suggests that augmentation with galantamine (GAL), which enhances cognition after TBI, may be indicated to confer benefits. OBJECTIVE: To test the hypothesis that 2 and 4 hours of EE paired with GAL will provide benefits comparable to 24 hours of EE alone. Moreover, all EE groups will perform better than the standard (STD)-housed GAL group. METHODS: Anesthetized rats received a TBI or sham injury and then were randomized to receive intraperitoneal injections of GAL (2 mg/kg) or saline vehicle (VEH; 1 mL/kg) beginning 24 hours after surgery and once daily while receiving EE for 2, 4, or 24 hours. Motor and cognitive assessments were conducted on postoperative days 1-5 and 14-19, respectively. RESULTS: Motor function was significantly improved in the TBI + 24-hour EE group versus the TBI + STD + VEH and TBI + STD + GAL groups ( P < .05). Cognitive performance was enhanced in all EE groups as well as in the TBI + STD + GAL versus TBI + STD + VEH ( P < .05). Moreover, the 2- and 4-hour EE groups receiving GAL did not differ from the 24-hour EE group ( P > .05) and performed better than GAL alone ( P < .05). CONCLUSIONS: The findings support the hypothesis and have clinical relevance because, often, only brief rehabilitation may be available in the clinic and, thus, augmenting with a pharmacotherapy such as GAL may lead to outcomes that are significantly better than either therapy alone.
Entities:
Keywords:
Morris water maze; behavioral outcome; controlled cortical impact; environmental enrichment; functional recovery; galantamine; learning and memory; traumatic brain injury
Authors: Benjamin Wells de Witt; Kathryn M Ehrenberg; Rose L McAloon; Amanda H Panos; Kaitlyn E Shaw; Priya V Raghavan; Elizabeth R Skidmore; Anthony E Kline Journal: Neurorehabil Neural Repair Date: 2010-12-26 Impact factor: 3.919
Authors: Ann N Hoffman; Rebecca R Malena; Brian P Westergom; Pallavi Luthra; Jeffrey P Cheng; Haris A Aslam; Ross D Zafonte; Anthony E Kline Journal: Neurosci Lett Date: 2007-12-04 Impact factor: 3.046
Authors: Anne Julie Frenette; Salmaan Kanji; Laura Rees; David R Williamson; Marc M Perreault; Alexis F Turgeon; Francis Bernard; Dean A Fergusson Journal: J Neurotrauma Date: 2011-10-17 Impact factor: 5.269
Authors: Anthony E Kline; Amy K Wagner; Brian P Westergom; Rebecca R Malena; Ross D Zafonte; Adam S Olsen; Christopher N Sozda; Pallavi Luthra; Monisha Panda; Jeffery P Cheng; Haris A Aslam Journal: Behav Brain Res Date: 2006-12-12 Impact factor: 3.332
Authors: Corina O Bondi; Bridgette D Semple; Linda J Noble-Haeusslein; Nicole D Osier; Shaun W Carlson; C Edward Dixon; Christopher C Giza; Anthony E Kline Journal: Neurosci Biobehav Rev Date: 2014-12-10 Impact factor: 8.989
Authors: Mioara D Manole; Marcus J A Hook; Melissa A Nicholas; Brittany P Nelson; Adanna C Liu; Quinn C Stezoski; Andrew P Rowley; Jeffrey P Cheng; Henry Alexander; Eleni H Moschonas; Corina O Bondi; Anthony E Kline Journal: Exp Neurol Date: 2020-11-02 Impact factor: 5.330
Authors: Eleni H Moschonas; Jacob B Leary; Kimiya Memarzadeh; Carine E Bou-Abboud; Kaitlin A Folweiler; Christina M Monaco; Jeffrey P Cheng; Anthony E Kline; Corina O Bondi Journal: Brain Res Date: 2020-10-26 Impact factor: 3.252
Authors: Naomi S Sta Maria; Saman Sargolzaei; Mayumi L Prins; Emily L Dennis; Robert F Asarnow; David A Hovda; Neil G Harris; Christopher C Giza Journal: Exp Neurol Date: 2019-05-02 Impact factor: 5.620